Search

Your search keyword '"Kwon, Chan-Young"' showing total 484 results
Start Over Author "Kwon, Chan-Young"
484 results on '"Kwon, Chan-Young"'

2. An evidence map on traditional medicine across health outcomes

Author

Ang, Lin, Song, Eunhye, Jong, Miek C, Alræk, Terje, Wider, Barbara, Choi, Tae-Young, Jun, Ji Hee, Lee, Boram, Choi, Yujin, Lee, Hye Won, Yang, Changsop, Yim, Mi Hong, Yamashita, Hitoshi, Ji, Zhaochen, Hu, Haiyin, Zhang, Junhua, Liu, Jianping, Chen, Yaolong, Qin, Yishan, Lu, Liming, Qu, Fan, Hansen, Odd-Magne, Kwon, Chan-Young, Leem, Jungtae, Lee, Hyangsook, Kim, Tae-Hun, Kim, Kun Hyung, Park, Sunju, Lee, Ye-Seul, Jang, Soobin, Won, Jiyoon, Choi, Jiae, Lee, Juah, Kim, Song-Yi, and Lee, Myeong Soo

Published
2024
Full Text
View/download PDF

18. The Effectiveness and Safety of Wu Tou Decoction on Rheumatoid Arthritis—A Systematic Review and Meta-Analysis.

Author

Moon, Jeong-Hyun, Park, Gyoungeun, Kwon, Chan-Young, Kim, Joo-Hee, Kim, Eun-Jung, Seo, Byung-Kwan, Lee, Seung-Deok, Hong, Seung-Ug, and Sung, Won-Suk

Subjects
CHINESE medicine, MEDICAL information storage & retrieval systems, MITOGEN-activated protein kinases, COMBINATION drug therapy, ALKALOIDS, PATIENT safety, RESEARCH funding, RHEUMATOID arthritis, HERBAL medicine, ANTIRHEUMATIC agents, TREATMENT effectiveness, META-analysis, DESCRIPTIVE statistics, BLOOD sedimentation, SYSTEMATIC reviews, MEDLINE, GENE expression, DRUG efficacy, MEDICAL databases, CONFIDENCE intervals, INTERLEUKINS, C-reactive protein, DISEASE progression, THERAPEUTICS, PHARMACODYNAMICS
Abstract

Rheumatoid arthritis (RA) is an autoimmune disease primarily affecting the joints and requires various treatments, including medication, injection, and physiotherapy. Wu tou decoction (WTD) is a traditional Chinese medicine prescribed for RA, with several articles documenting its effectiveness in RA treatment. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of WTD for RA. We searched for randomized controlled trials (RCTs) comparing WTD with conventional treatments (including medication, injection, and physiotherapy) from its inception to May 2024. Primary outcomes were disease activity scores, including effective rate, tender joint count, and morning stiffness. Secondary outcomes comprised blood test results (erythrocyte sedimentation rate, C-reactive protein, and rheumatoid factor) and adverse events. Nineteen RCTs involving 1794 patients were included. Statistically, WTD demonstrated better improvement than conventional treatments (18 medications and 1 injection) across the effective rate, joint scale, and blood tests, regardless of the treatment type (monotherapy or combination therapy). Adverse events were reported in 11 studies, with no statistical differences observed between them. The numerical results showed that WTD may offer potential benefits for managing RA. However, the significant discrepancy between clinical practice and the low quality of the RCTs remains a limitation. Therefore, further well-designed studies with larger patient cohorts are needed to draw definitive conclusions. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results